- Home
- CLDX vs ADEA Comparison
CLDX vs ADEA Comparison
Compare CLDX & ADEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- ADEA
- Stock Information
- Founded
- CLDX N/A
- ADEA 1990
- Country
- CLDX United States
- ADEA United States
- Employees
- CLDX N/A
- ADEA N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ADEA Computer Software: Prepackaged Software
- Sector
- CLDX Health Care
- ADEA Technology
- Exchange
- CLDX Nasdaq
- ADEA Nasdaq
- Market Cap
- CLDX 1.2B
- ADEA 1.3B
- IPO Year
- CLDX 2008
- ADEA N/A
- Fundamental
- Price
- CLDX $19.44
- ADEA $12.21
- Analyst Decision
- CLDX Buy
- ADEA Strong Buy
- Analyst Count
- CLDX 8
- ADEA 3
- Target Price
- CLDX $54.29
- ADEA $18.33
- AVG Volume (30 Days)
- CLDX 856.2K
- ADEA 637.6K
- Earning Date
- CLDX 05-05-2025
- ADEA 05-05-2025
- Dividend Yield
- CLDX N/A
- ADEA 1.67%
- EPS Growth
- CLDX N/A
- ADEA N/A
- EPS
- CLDX N/A
- ADEA 0.57
- Revenue
- CLDX $7,020,000.00
- ADEA $376,024,000.00
- Revenue This Year
- CLDX N/A
- ADEA $10.83
- Revenue Next Year
- CLDX N/A
- ADEA $3.41
- P/E Ratio
- CLDX N/A
- ADEA $21.07
- Revenue Growth
- CLDX 1.99
- ADEA N/A
- 52 Week Low
- CLDX $14.40
- ADEA $9.68
- 52 Week High
- CLDX $47.00
- ADEA $17.46
- Technical
- Relative Strength Index (RSI)
- CLDX 54.30
- ADEA 43.23
- Support Level
- CLDX $17.45
- ADEA $11.52
- Resistance Level
- CLDX $20.36
- ADEA $12.28
- Average True Range (ATR)
- CLDX 1.21
- ADEA 0.57
- MACD
- CLDX 0.44
- ADEA 0.07
- Stochastic Oscillator
- CLDX 81.21
- ADEA 70.14
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About ADEA Adeia Inc.
Adeia Inc is a consumer and entertainment product/solutions licensing company. Its only operating segment being Intellectual Property (IP) Licensing. In the IP segment, it primarily license innovations to leading companies in the broader entertainment industry, and those developing new technologies that will help drive this industry forward. It includes Pay-TV, Consumer Electronics, Connected Car, and Media Platform.